From Medscape Oncology

Coverage from the

American Society of Clinical Oncology (ASCO) 2022

June 03 - 06, 2022; Chicago, IL and Virtual/Online

June 03 - 06, 2022 Chicago, IL and Virtual/Online

EHA 2022 Similar Survival, Less Toxicity With Decitabine vs Chemo in AML For patients with acute myeloid leukemia, treatment with decitabine prior to stem cell transplantation had similar overall survival and much less toxicity compared with intensive chemotherapy.
Medscape Medical News, June 12, 2022
EHA 2022 A New First-line Regimen for Advanced Hodgkin Lymphoma? Patients receiving brentuximab vedotin plus chemotherapy demonstrated a significant improvement in overall survival at 6 years compared with those on standard chemotherapy.
Medscape Medical News, June 10, 2022

Conference News

ASCO 2022 Pembrolizumab for Melanoma Bittersweet, Doctor Says
Medscape Medical News, July 15, 2022
ASCO 2022 High Deductible Insurance and Delayed Advanced Cancer Diagnosis
Medscape Medical News, July 14, 2022
ASCO 2022 Melanoma Incidence Up, but Death Rates Down
Medscape Medical News, June 29, 2022
ASCO 2022 How FDA Is Working to Improve Oncology Drug Development
Medscape Medical News, June 24, 2022
ASCO 2022 Large Benefit From Ovarian Function Suppression in Breast Cancer
Medscape Medical News, June 23, 2022
ASCO 2022 Forget Moonshot: Cancer Patients Right Now Need 'Groundshot'
Medscape Medical News, June 21, 2022
ASCO 2022 Moral Distress in Oncology Practice Needs Tackling Head-on
Medscape Medical News, June 17, 2022
ASCO 2022 Breast Cancer Deaths Take a Big Dip Because of New Medicines
Medscape Medical News, June 15, 2022
ASCO 2022 Momelotinib Hits the Mark for Deadly Bone Marrow Cancer
Medscape Medical News, June 15, 2022
ASCO 2022 Bacterial Decolonization Prevents Acute Radiation Dermatitis
Medscape Medical News, June 14, 2022
ASCO 2022 Clinical Trials Stuck in the '80s: 'We Need to Embrace the Now'
Medscape Medical News, June 14, 2022
ASCO 2022 How Telehealth Cancer Rehab Program Overcame Historic Barriers
Medscape Medical News, June 13, 2022
ASCO 2022 Acetaminophen Linked to Diminished Response to Immunotherapy in Cancer
Medscape Medical News, June 8, 2022
ASCO 2022 Select Patients With Breast Cancer May Skip RT After Lumpectomy
Medscape Medical News, June 7, 2022
ASCO 2022 Treating Bone Loss Ups Survival for Patients With Breast Cancer
Medscape Medical News, June 7, 2022
ASCO 2022 Women With HER2+ Metastatic Breast Cancer Are Living Longer
Medscape Medical News, June 7, 2022

ASCO 2022 Pseudocirrhosis in Breast Cancer May Signal Liver Metastases
Medscape Medical News, June 7, 2022
ASCO 2022 Targeted Therapy an 'Important Advance' in Childhood Glioma
Medscape Medical News, June 6, 2022
ASCO 2022 Enhertu Benefit in HER2-Low Breast Cancer: 'Practice Changing'
Medscape Medical News, June 6, 2022
ASCO 2022 Teclistamab Shows 'Promising' Activity in R/R Multiple Myeloma
Medscape Medical News, June 6, 2022
ASCO 2022 Sacituzumab a 'Step Forward' in Breast Cancer Unmet Need
Medscape Medical News, June 6, 2022
ASCO 2022 First-Line Treatment in Newly Diagnosed Multiple Myeloma
Medscape Medical News, June 5, 2022
ASCO 2022 International Trial Finds Best Regimen for Ewing Sarcoma
Medscape Medical News, June 5, 2022
ASCO 2022 Panitumumab Beats Bevacizumab in Left-Sided mCRC
Medscape Medical News, June 5, 2022
ASCO 2022 'Great Optimism' Over Complete Responses in dMMR Rectal Cancer
Medscape Medical News, June 5, 2022
ASCO 2022 ctDNA Identifies Colon Cancer Patients Who Can Skip Chemo
Medscape Medical News, June 4, 2022
ASCO 2022 Adagrasib Shows Durable Benefit in KRAS-Mutated NSCLC
Medscape Medical News, June 4, 2022
ASCO 2022 Improved Survival in Subset of Advanced Pancreatic Cancer
Medscape Medical News, June 4, 2022
ASCO 2022 'Profound' Results With Ibrutinib Add-On in Mantle Cell Lymphoma
Medscape Medical News, June 4, 2022
ASCO 2022 Increased Social Services Spending Ups Cancer Survival of Blacks
Medscape Medical News, May 27, 2022
ASCO 2022 Telemedicine in Cancer Care: Not All Patients Can Access
Medscape Medical News, May 27, 2022
ASCO 2022 Oncologists Flock to Chicago for ASCO, After 2 Years Online
Medscape Medical News, May 26, 2022

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Medscape Oncology Perspectives

Myth Busting: Do Systemic Therapies Affect Brain Metastases?
Mark G. Kris, MD
'Real-World' Data: Watchword or Accurate Description?
Kathy D. Miller, MD
Highlights in Renal Cell Carcinoma From ASCO 2022
Brian I. Rini, MD
Highlights in Early Breast Cancer From ASCO 2022
Ann H. Partridge, MD, MPH
'It's an ADC World': New Breast Cancer Data From ASCO 2022
Kathy D. Miller, MD; Harold J. Burstein, MD, PhD
Key Abstracts in Metastatic Breast Cancer From ASCO 2022
Harold J. Burstein, MD, PhD
Key Studies in Bladder Cancer From ASCO 2022
Petros Grivas, MD, PhD
New Options in Myelodysplastic Syndromes From ASCO 2022
Amy DeZern, MD
Multiple Myeloma Highlights From ASCO 2022
Jonathan Kaufman, MD
Melanoma and Skin Cancer Highlights From ASCO 2022
Jeffrey S. Weber, MD, PhD
Novel Strategies in Advanced NSCLC From ASCO 2022
Jonathan Goldman, MD
GI Oncology at ASCO 2022: Tumor Sidedness, ctDNA, and MRD
John L. Marshall, MD; Mark A. Lewis, MD

Popular News from ASCO 2021

In Previous Year, 70% of Oncologists Reported Sexual Harassment A survey of 271 full-time US oncologists found that the majority experienced gender harassment, unwanted sexual advances, sexual coercion, or some combination of the three.
Medscape Medical News, Jun 07, 2021
'Check Your Assumptions at the Door,' Advises Outlier Patient A young Black woman diagnosed with melanoma twice before she turned 30 describes how off-the-mark comments from healthcare providers and others led her to feel marginalized and silenced.
Medscape Medical News, Jun 15, 2021
ASCO 2021's Best Trials Proved We Can Do More With Less Dr Mark Lewis celebrates this year's annual meeting, which showed the positives of subtracting chemotherapy.
Medscape Medical News, Jul 14, 2021

Previous Coverage